2018
DOI: 10.15252/embj.201899847
|View full text |Cite
|
Sign up to set email alerts
|

A selective ER ‐phagy exerts procollagen quality control via a Calnexin‐ FAM 134B complex

Abstract: Autophagy is a cytosolic quality control process that recognizes substrates through receptor‐mediated mechanisms. Procollagens, the most abundant gene products in Metazoa, are synthesized in the endoplasmic reticulum (ER), and a fraction that fails to attain the native structure is cleared by autophagy. However, how autophagy selectively recognizes misfolded procollagens in the ER lumen is still unknown. We performed siRNA interference, CRISPR‐Cas9 or knockout‐mediated gene deletion of candidate autophagy and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
212
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 187 publications
(218 citation statements)
references
References 51 publications
(77 reference statements)
5
212
1
Order By: Relevance
“…The RHD of FAM134B interacts with the TM domain of CANX that binds to PC1 molecules most likely through the N-terminal luminal domain. Consistently, the inhibition of CANX function prevents FAM134B interaction with PC, suggesting that CANX bridges ER luminal PC to FAM134B at the ER membrane [24].…”
Section: The 'Er-phagy' Pathwaymentioning
confidence: 64%
“…The RHD of FAM134B interacts with the TM domain of CANX that binds to PC1 molecules most likely through the N-terminal luminal domain. Consistently, the inhibition of CANX function prevents FAM134B interaction with PC, suggesting that CANX bridges ER luminal PC to FAM134B at the ER membrane [24].…”
Section: The 'Er-phagy' Pathwaymentioning
confidence: 64%
“…This reflects a form of hereditary sensory and autonomic neuropathy (HSAN type II) in humans caused by FAM134B nonsense mutations . However, it remains to be determined whether the primary cause of these neuropathies is defective FAM134B‐mediated procollagen (PC) quality control within the ER lumen, as might be suggested by the in vitro study described above . No effect of Fam134b knockout was reported in other organs, albeit in unchallenged mice.…”
Section: Er‐phagy Pathways: Mechanisms and Importancementioning
confidence: 98%
“…Clearance of an overload of misfolded proteins, large amounts of membranes or ER contents could indeed be called bulk ER‐phagy and presumably depends on a receptor with a broad substrate spectrum. In contrast, dependency on co‐receptors, like in the case of FAM134B and misfolded procollagen , might speak to a more targeted and specific ER‐phagy receptor with a narrow substrate spectrum. Of note, RTN3 specifically regulates the elimination of prohormone aggregates, in particular Akita proinsulin aggregates, from the ER lumen .…”
Section: Er‐phagy Receptors: Different Players Different Substrates mentioning
confidence: 99%
“…In principle, the following possibilities exist and, most probably, a combination of those takes place: Activation via PTMs: PTMs can reveal or mask binding interfaces, which are necessary for the oligomerization, and modulation of receptor binding affinity to its substrates and to autophagic membranes. Co‐receptors, auxiliary and scaffold proteins (i.e. ER chaperones or ER resident proteins): clustering as well as substrate binding could be facilitated via chaperones, this is likely the case with Calnexin in misfolded procollagen elimination . Multiple chaperones could serve the same receptor or recognize the same intraluminal ER protein aggregates.…”
Section: How Is Er‐phagy Activated and What Kind Of Regulation Levelsmentioning
confidence: 99%
See 1 more Smart Citation